跳至主要内容
临床试验/NCT00199056
NCT00199056已完成4 期

Multicenter Trial for Treatment of Acute Lymphocytic Leukemia in Adults (Pilot Study 06/99)

Goethe University2 个研究点 分布在 1 个国家目标入组 225 人开始时间: 1999年10月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
225
试验地点
2
主要终点
Remission rate,Remission duration,Disease free survival,Overall survival

研究概览

简要总结

The study evaluates the efficacy and tolerability of an intensified induction and consolidation therapy. Thereafter patients receive individualised treatment stratified according to relapse risk with stem cell transplantation for patients with high and very high risk of relapse. Patients with standard risk receive further consolidation and reinduction chemotherapy. In parallel minimal residual disease (MRD) is evaluated. A MRD based risk stratification and treatment decision is developed.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute lymphoblastic leukemia (pro-B, common, pre-B, early T, T)
  • Age 15-65 yrs (*55-65 years if biologically younger according to general condition)

排除标准

  • Severe comorbidity
  • Cytostatic pre-treatment
  • Pregnancy
  • Missing written informed consent

结局指标

主要结局

Remission rate,Remission duration,Disease free survival,Overall survival

次要结局

  • Time and dose compliance,Realisation of SCT,Toxicity according to WHO,Course of MRD

研究者

发起方
Goethe University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicola Goekbuget

Head of GMALL

Goethe University

研究点 (2)

Loading locations...

相似试验